Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO Oversight Of FDA Performance Included In House Device User Fee Bill

This article was originally published in The Gray Sheet

Executive Summary

FDA's ability to achieve timely review of premarket applications will be closely monitored by Congress and industry if the agency implements a planned medical device user fee program

You may also be interested in...



Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn

AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating

Device Industry Extols Medicare Passage Despite Competitive Bidding Thorn

AAHomecare plans to meet with CMS officials Dec. 3 to seek clarification on DME competitive bidding provisions in the Medicare reform bill, following whirlwind floor votes and last-minute negotiating

Biologics Center 510(k) Reviews Show Improvement In Early Fiscal ’03 – CBER

Increased willingness by Center for Biologics Evaluation & Research reviewers to participate in interactive reviews could help reduce review cycles and times for devices and in vitro diagnostics at the biologics center, attorney Jonathan Kahan suggested

Related Content

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel